CSL Ltd. (CSLLY)
31.73
+0.93
(+3.02%)
USD |
OTCM |
Sep 17, 16:00
CSL Price : 31.73 for Sept. 17, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | 31.80 | 31.80 | 31.63 | 31.73 | 99484.00 |
| Sep 16, 2026 | 31.10 | 31.53 | 30.60 | 30.80 | 86580.00 |
| Sep 15, 2026 | 31.54 | 31.95 | 31.00 | 31.66 | 215277.0 |
| Sep 14, 2026 | 30.50 | 30.79 | 30.40 | 30.72 | 86773.00 |
| Sep 11, 2026 | 30.00 | 30.03 | 29.49 | 29.91 | 139723.0 |
| Sep 10, 2026 | 30.40 | 30.98 | 30.10 | 30.16 | 153998.0 |
| Sep 09, 2026 | 31.00 | 31.23 | 30.93 | 31.00 | 72992.00 |
| Sep 08, 2026 | 30.23 | 31.67 | 30.23 | 31.55 | 92280.00 |
| Sep 04, 2026 | 31.95 | 31.95 | 31.38 | 31.61 | 42735.00 |
| Sep 03, 2026 | 31.56 | 32.75 | 31.56 | 31.70 | 102853.0 |
| Sep 02, 2026 | 31.06 | 31.43 | 31.06 | 31.30 | 109970.0 |
| Sep 01, 2026 | 30.72 | 30.97 | 30.58 | 30.63 | 80736.00 |
| Aug 31, 2026 | 30.69 | 30.79 | 30.51 | 30.56 | 230325.0 |
| Aug 28, 2026 | 30.97 | 31.14 | 30.76 | 30.92 | 125244.0 |
| Aug 27, 2026 | 31.43 | 31.43 | 31.00 | 31.34 | 102987.0 |
| Aug 26, 2026 | 30.78 | 31.00 | 30.78 | 31.00 | 107070.0 |
| Aug 25, 2026 | 30.86 | 31.36 | 30.86 | 31.36 | 150050.0 |
| Aug 24, 2026 | 30.26 | 30.42 | 30.00 | 30.10 | 432662.0 |
| Aug 21, 2026 | 30.33 | 30.36 | 30.06 | 30.26 | 151763.0 |
| Aug 20, 2026 | 30.25 | 30.57 | 30.25 | 30.44 | 130115.0 |
| Aug 19, 2026 | 29.40 | 29.82 | 29.40 | 29.79 | 219177.0 |
| Aug 18, 2026 | 28.24 | 28.26 | 27.92 | 28.10 | 139086.0 |
| Aug 17, 2026 | 24.01 | 24.10 | 23.95 | 23.95 | 70880.00 |
| Aug 14, 2026 | 24.26 | 24.27 | 24.05 | 24.11 | 70082.00 |
| Aug 13, 2026 | 24.25 | 24.42 | 24.19 | 24.21 | 126545.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Immutep Ltd. | 0.2819 |
| Ceryvyn Therapeutics Ltd. | 0.0232 |
| Propanc Biopharma, Inc. | 0.6326 |
| Mesoblast Ltd. | 15.04 |
| Actinogen Medical Ltd. | 0.035 |
Price Related Metrics
| PS Ratio | 3.891 |
| Price to Free Cash Flow | 27.31 |
| Earnings Yield | -4.27% |
| Market Cap | 60.78B |
| Operating PE Ratio | 15.28 |
| Normalized PE Ratio | 21.36 |